phenylalanine and African Sleeping Sickness

phenylalanine has been researched along with African Sleeping Sickness in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (40.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (60.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amendola, G; Chouchene, K; Cosconati, S; Ettari, R; Grasso, S; Gut, J; Hellmich, UA; Krauth-Siegel, RL; Previti, S; Rosenthal, PJ; Schirmeister, T; Schmid, I; Ulrich, K; Wagner, A; Wich, PR; Zappalà, M	1
Acevedo, O; Cáceres, TB; Hevel, JM; Ippolito, N; Li, J; Price, OM; Qu, J; Thakur, A	1
Nicoll-Griffith, DA	1
Hall, JE; Price, CC; Seed, JR	1
Hall, JE; Sechelski, J; Seed, JR	1

Reviews

1 review(s) available for phenylalanine and African Sleeping Sickness

Article	Year
Use of cysteine-reactive small molecules in drug discovery for trypanosomal disease. Expert opinion on drug discovery, 2012, Volume: 7, Issue:4 Topics: Animals; Biphenyl Compounds; Catalytic Domain; Cathepsin K; Chagas Disease; Cysteine; Cysteine Endopeptidases; Cysteine Proteases; Cysteine Proteinase Inhibitors; Dipeptides; Dogs; Drug Discovery; Humans; Leishmaniasis; Mice; Phenylalanine; Piperazines; Prodrugs; Protein Binding; Protozoan Proteins; Tosyl Compounds; Trypanocidal Agents; Trypanosoma; Trypanosomiasis, African; Vinyl Compounds	2012

Article

Year

Use of cysteine-reactive small molecules in drug discovery for trypanosomal disease.

Expert opinion on drug discovery, 2012, Volume: 7, Issue:4

Topics: Animals; Biphenyl Compounds; Catalytic Domain; Cathepsin K; Chagas Disease; Cysteine; Cysteine Endopeptidases; Cysteine Proteases; Cysteine Proteinase Inhibitors; Dipeptides; Dogs; Drug Discovery; Humans; Leishmaniasis; Mice; Phenylalanine; Piperazines; Prodrugs; Protein Binding; Protozoan Proteins; Tosyl Compounds; Trypanocidal Agents; Trypanosoma; Trypanosomiasis, African; Vinyl Compounds

2012

Other Studies

4 other study(ies) available for phenylalanine and African Sleeping Sickness

Article	Year
Development of Novel Peptide-Based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs). Journal of medicinal chemistry, 2017, 08-24, Volume: 60, Issue:16 Topics: Antimalarials; Carbamates; Cathepsin L; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Dipeptides; HeLa Cells; Humans; Hydrogen Bonding; Malaria; Molecular Docking Simulation; Molecular Dynamics Simulation; Neglected Diseases; Phenylalanine; Plasmodium falciparum; Stereoisomerism; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African	2017
Phe71 in Type III Trypanosomal Protein Arginine Methyltransferase 7 (TbPRMT7) Restricts the Enzyme to Monomethylation. Biochemistry, 2018, 02-27, Volume: 57, Issue:8 Topics: Amino Acid Sequence; Animals; Catalytic Domain; Methylation; Molecular Dynamics Simulation; Phenylalanine; Point Mutation; Protein-Arginine N-Methyltransferases; Rats; Sequence Alignment; Substrate Specificity; Trypanosoma brucei brucei; Trypanosomiasis, African	2018
A physiological mechanism to explain pathogenesis in African trypanosomiasis. Contributions to microbiology and immunology, 1983, Volume: 7 Topics: Animals; Arvicolinae; Creatinine; Humans; Ketoglutaric Acids; Phenylalanine; Phenylpyruvic Acids; Proteinuria; Pyruvates; Pyruvic Acid; Trypanosoma brucei brucei; Trypanosomiasis, African	1983
Phenylalanine metabolism in Microtus montanus chronically infected with Trypanosoma brucei gambiense. Comparative biochemistry and physiology. B, Comparative biochemistry, 1982, Volume: 71, Issue:2 Topics: Animals; Arvicolinae; Chromatography, High Pressure Liquid; Phenylalanine; Phenylpyruvic Acids; Trypanosoma brucei brucei; Trypanosomiasis, African	1982